EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ALKBH5 gene polymorphisms and risk of neuroblastoma in Chinese children from Jiangsu Province

Qian Guan, Xinxin Zhang, Jiabin Liu, Chunlei Zhou, Jinhong Zhu, Haiyan Wu, Zhenjian Zhuo iD, Jing He

Cancer Innovation · 2024

DOI: 10.1002/cai2.103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Innovation, 2024. Verfasst von Qian Guan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Diseas…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Postdoctoral Science Foundation of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neuroblastoma is one of the most common extracranial malignant solid tumors in children. AlkB homolog 5 (ALKBH5) is an RNA N6‐methyladenosine (m6A) demethylase that plays a critical role in tumorigenesis and development. We assessed the association between single nucleotide polymorphisms (SNPs) in ALKBH5 and the risk of neuroblastoma in a case‐control study including 402 patients and 473 non‐cancer controls.

Methods

Genotyping was determined by the TaqMan method. The association between ALKBH5 polymorphisms (rs1378602 and rs8400) and the risk of neuroblastoma was evaluated using the odds ratio (OR) and 95% confidence interval (CI).

Results

We found no strong association of ALKBH5 rs1378602 and rs8400 with neuroblastoma risk. Further stratification analysis by age, sex, primary site, and clinical stage showed that the rs1378602 AG/AA genotype was associated with a lower risk of neuroblastoma in males (adjusted OR = 0.58, 95% CI = 0.35–0.97, p = 0.036) and children with retroperitoneal neuroblastoma (adjusted OR = 0.58, 95% CI = 0.34–0.98, p = 0.040).

Conclusions

ALKBH5 SNPs do not seem to be associated with neuroblastoma risk. More studies are required to confirm this negative result and reveal the relationship between gene polymorphisms of the m6A modifier ALKBH5 and neuroblastoma.

Schlagwörter

Stichwörter der Autor:innen

ALKBH5neuroblastomapolymorphismsusceptibility

Autor:innen und Institutionen

  • Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangdong Provincial Clinical Research Center for Child Health, Gua…
  • Department of Pathology Children's Hospital of Nanjing Medical University Nanjing Jiangsu China.
  • Department of Clinical Laboratory, Biobank Harbin Medical University Cancer Hospital Harbin Heilongjiang China.
  • Laboratory Animal Center, School of Chemical Biology and Biotechnology Peking University Shenzhen Graduate School Shenzhen Guangdong China.

ORCID-Profile: Zhenjian Zhuo

Förderung

  • Postdoctoral Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Guan, Q., Zhang, X., Liu, J., Zhou, C., Zhu, J., Wu, H., Zhuo, Z., & He, J. (2024). ALKBH5 gene polymorphisms and risk of neuroblastoma in Chinese children from Jiangsu Province. Cancer Innovation. https://doi.org/10.1002/cai2.103

Vancouver

Guan Q, Zhang X, Liu J, Zhou C, Zhu J, Wu H, et al. ALKBH5 gene polymorphisms and risk of neuroblastoma in Chinese children from Jiangsu Province. Cancer Innovation. 2024. doi:10.1002/cai2.103

BibTeX
@article{Guan2024,
  author = {Guan, Qian and Zhang, Xinxin and Liu, Jiabin and Zhou, Chunlei and Zhu, Jinhong and Wu, Haiyan and Zhuo, Zhenjian and He, Jing},
  title = {ALKBH5 gene polymorphisms and risk of neuroblastoma in Chinese children from Jiangsu Province},
  journal = {Cancer Innovation},
  year = {2024},
  doi = {10.1002/cai2.103}
}
Kostenlos starten →